Completed Psychology & Behaviour Public Health & Healthcare

Midland Hub for Trials Methodology Research at University of Birmingham

In plain English

AI plain-English summary

Clinical trials are the final hurdle before a new treatment reaches patients, but the way they are designed and run can make the difference between a clear answer and a wasted opportunity. This project creates a regional hub at the University of Birmingham to study how trials themselves should work. The problem is that many trials are poorly planned, ask the wrong questions, or analyse data in ways that produce unreliable results. That wastes time, money, and patient goodwill. The hub will investigate better methods for designing, conducting, and analysing trials, then provide advice, support, and training to researchers and the public. If this succeeds, the impact is indirect but powerful. Better trial methods mean faster, cheaper, and more reliable answers about which treatments work. That could shorten the years-long gap between a promising drug discovery and its approval for use. The hub will not develop any specific treatment itself. Instead, it will improve the infrastructure that quietly determines whether good science translates into real patient benefit. More efficient trials ultimately deliver beneficial treatments to patients sooner.

View original technical description
Clinical trials test potential treatments in humans to see if they should be approved for wider use in the general population. Any new treatment must be extensively tested to check that it benefits patients, is safe and doesn t have unacceptable side effects. Most often the treatment is a drug, but it could be a medical device, a surgical or physical procedure, a therapy or an intervention such as health promotion. Volunteers are recruited into the clinical trial to undergo the new treatment and usually the trial will include a group who just receive the standard treatment. In this way, the outcome of patients on the new treatment can be compared to the standard to see if it is beneficial. Planning how the trial will be run and making sure it addresses the right questions are important to ensure that the results from the trial will be useful. Interpreting the data that is collected in the trial also needs to guarantee that valid conclusions are reached. The plan for this research is to create a regional facility at the University of Birmingham in which to investigate the best ways to design, conduct and analyse trials, providing advice, support and training to those carrying out trials and to the public. Ultimately this will result in beneficial treatments being delivered to patients more efficiently.

View the original record at the funder ↗

Researchers

Brendan Delaney (Co-Investigator)Frederick Hobbs (Co-Investigator)Jonathan Deeks (Co-Investigator)Keith Wheatley (Co-Investigator)Lucinda Billingham (Principal Investigator)Martin Zeegers (Co-Investigator)Melanie Calvert (Co-Investigator)Nick Freemantle (Co-Investigator)Philip Johnson (Co-Investigator)Richard Gray (Co-Investigator)Richard Lilford (Co-Investigator)Stirling Bryan (Co-Investigator)Sue Wilson (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge)
MRC North West Hub for Trials Methodology Research
Clinical Research Infrastructure and Trials Platform
MRC Clinical Trials Unit as the London Hub for Trials Methodology Research
Innovative Mental Health Clinical Trials Methodology Hub

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.